后 COVID-19 大流行时代针对耐多药生物的接触预防措施的实施情况:全国新发感染网络 (EIN) 最新调查。

IF 3 4区 医学 Q2 INFECTIOUS DISEASES
Infection Control and Hospital Epidemiology Pub Date : 2024-06-01 Epub Date: 2024-02-14 DOI:10.1017/ice.2024.11
Jessica R Howard-Anderson, Lindsey B Gottlieb, Susan E Beekmann, Philip M Polgreen, Jesse T Jacob, Daniel Z Uslan
{"title":"后 COVID-19 大流行时代针对耐多药生物的接触预防措施的实施情况:全国新发感染网络 (EIN) 最新调查。","authors":"Jessica R Howard-Anderson, Lindsey B Gottlieb, Susan E Beekmann, Philip M Polgreen, Jesse T Jacob, Daniel Z Uslan","doi":"10.1017/ice.2024.11","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To understand how healthcare facilities employ contact precautions for patients with multidrug-resistant organisms (MDROs) in the post-coronavirus disease 2019 (COVID-19) era and explore changes since 2014.</p><p><strong>Design: </strong>Cross-sectional survey.</p><p><strong>Participants: </strong>Emerging Infections Network (EIN) physicians involved in infection prevention or hospital epidemiology.</p><p><strong>Methods: </strong>In September 2022, we sent via email an 8-question survey on contact precautions and adjunctive measures to reduce MDRO transmission in inpatient facilities. We also asked about changes since the COVID-19 pandemic. We used descriptive statistics to summarize data and compared results to a similar survey administered in 2014.</p><p><strong>Results: </strong>Of 708 EIN members, 283 (40%) responded to the survey and 201 reported working in infection prevention. A majority of facilities (66% and 69%) routinely use contact precautions for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) and vancomycin-resistant enterococci (VRE) respectively, compared to 93% and 92% in 2014. Nearly all (>90%) use contact precautions for <i>Candida auris</i>, carbapenem-resistant Enterobacterales (CRE), and carbapenem-resistant <i>Acinetobacter baumannii</i>. More variability was reported for carbapenem-resistant <i>Pseudomonas aeruginosa</i> and extended-spectrum β-lactamase-producing gram-negative organisms. Compared to 2014, fewer hospitals perform active surveillance for MRSA and VRE. Overall, 90% of facilities used chlorhexidine gluconate bathing in all or select inpatients, and 53% used ultraviolet light or hydrogen peroxide vapor disinfection at discharge. Many respondents (44%) reported changes to contact precautions since COVID-19 that remain in place.</p><p><strong>Conclusions: </strong>Heterogeneity exists in the use of transmission-based precautions and adjunctive infection prevention measures aimed at reducing MDRO transmission. This variation reflects a need for updated and specific guidance, as well as further research on the use of contact precautions in healthcare facilities.</p>","PeriodicalId":13663,"journal":{"name":"Infection Control and Hospital Epidemiology","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11102826/pdf/","citationCount":"0","resultStr":"{\"title\":\"Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.\",\"authors\":\"Jessica R Howard-Anderson, Lindsey B Gottlieb, Susan E Beekmann, Philip M Polgreen, Jesse T Jacob, Daniel Z Uslan\",\"doi\":\"10.1017/ice.2024.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To understand how healthcare facilities employ contact precautions for patients with multidrug-resistant organisms (MDROs) in the post-coronavirus disease 2019 (COVID-19) era and explore changes since 2014.</p><p><strong>Design: </strong>Cross-sectional survey.</p><p><strong>Participants: </strong>Emerging Infections Network (EIN) physicians involved in infection prevention or hospital epidemiology.</p><p><strong>Methods: </strong>In September 2022, we sent via email an 8-question survey on contact precautions and adjunctive measures to reduce MDRO transmission in inpatient facilities. We also asked about changes since the COVID-19 pandemic. We used descriptive statistics to summarize data and compared results to a similar survey administered in 2014.</p><p><strong>Results: </strong>Of 708 EIN members, 283 (40%) responded to the survey and 201 reported working in infection prevention. A majority of facilities (66% and 69%) routinely use contact precautions for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) and vancomycin-resistant enterococci (VRE) respectively, compared to 93% and 92% in 2014. Nearly all (>90%) use contact precautions for <i>Candida auris</i>, carbapenem-resistant Enterobacterales (CRE), and carbapenem-resistant <i>Acinetobacter baumannii</i>. More variability was reported for carbapenem-resistant <i>Pseudomonas aeruginosa</i> and extended-spectrum β-lactamase-producing gram-negative organisms. Compared to 2014, fewer hospitals perform active surveillance for MRSA and VRE. Overall, 90% of facilities used chlorhexidine gluconate bathing in all or select inpatients, and 53% used ultraviolet light or hydrogen peroxide vapor disinfection at discharge. Many respondents (44%) reported changes to contact precautions since COVID-19 that remain in place.</p><p><strong>Conclusions: </strong>Heterogeneity exists in the use of transmission-based precautions and adjunctive infection prevention measures aimed at reducing MDRO transmission. This variation reflects a need for updated and specific guidance, as well as further research on the use of contact precautions in healthcare facilities.</p>\",\"PeriodicalId\":13663,\"journal\":{\"name\":\"Infection Control and Hospital Epidemiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11102826/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infection Control and Hospital Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1017/ice.2024.11\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Control and Hospital Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/ice.2024.11","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的:了解在2019年后冠状病毒病(COVID-19)时代,医疗机构如何对耐多药病菌(MDRO)患者采取接触预防措施,并探讨自2014年以来的变化:横断面调查:新发感染网络(EIN)中从事感染预防或医院流行病学的医生:2022 年 9 月,我们通过电子邮件发送了一份包含 8 个问题的调查问卷,内容涉及接触预防措施和辅助措施,以减少 MDRO 在住院设施中的传播。我们还询问了自 COVID-19 大流行以来的变化情况。我们使用描述性统计来总结数据,并将结果与 2014 年进行的类似调查进行比较:在 708 名 EIN 成员中,有 283 人(40%)对调查做出了回应,其中 201 人称自己从事感染预防工作。大多数医疗机构(66%和69%)分别对耐甲氧西林金黄色葡萄球菌(MRSA)和耐万古霉素肠球菌(VRE)采取常规接触预防措施,而2014年这一比例分别为93%和92%。几乎所有人(>90%)都对念珠菌、耐碳青霉烯类肠杆菌(CRE)和耐碳青霉烯类鲍曼不动杆菌采取接触预防措施。耐碳青霉烯类铜绿假单胞菌和产扩展谱β-内酰胺酶革兰阴性菌的报告差异较大。与 2014 年相比,对 MRSA 和 VRE 进行主动监测的医院数量有所减少。总体而言,90%的医院对所有或部分住院患者使用洗必泰葡萄糖酸盐擦浴,53%的医院在出院时使用紫外线或过氧化氢蒸汽消毒。许多受访者(44%)报告了自 COVID-19 以来对接触性预防措施所做的更改,这些更改仍在实施中:结论:在使用基于传播的预防措施和辅助感染预防措施以减少 MDRO 传播方面存在差异。这种差异反映出需要更新具体的指南,并进一步研究医疗机构中接触预防措施的使用情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.

Objective: To understand how healthcare facilities employ contact precautions for patients with multidrug-resistant organisms (MDROs) in the post-coronavirus disease 2019 (COVID-19) era and explore changes since 2014.

Design: Cross-sectional survey.

Participants: Emerging Infections Network (EIN) physicians involved in infection prevention or hospital epidemiology.

Methods: In September 2022, we sent via email an 8-question survey on contact precautions and adjunctive measures to reduce MDRO transmission in inpatient facilities. We also asked about changes since the COVID-19 pandemic. We used descriptive statistics to summarize data and compared results to a similar survey administered in 2014.

Results: Of 708 EIN members, 283 (40%) responded to the survey and 201 reported working in infection prevention. A majority of facilities (66% and 69%) routinely use contact precautions for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) respectively, compared to 93% and 92% in 2014. Nearly all (>90%) use contact precautions for Candida auris, carbapenem-resistant Enterobacterales (CRE), and carbapenem-resistant Acinetobacter baumannii. More variability was reported for carbapenem-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing gram-negative organisms. Compared to 2014, fewer hospitals perform active surveillance for MRSA and VRE. Overall, 90% of facilities used chlorhexidine gluconate bathing in all or select inpatients, and 53% used ultraviolet light or hydrogen peroxide vapor disinfection at discharge. Many respondents (44%) reported changes to contact precautions since COVID-19 that remain in place.

Conclusions: Heterogeneity exists in the use of transmission-based precautions and adjunctive infection prevention measures aimed at reducing MDRO transmission. This variation reflects a need for updated and specific guidance, as well as further research on the use of contact precautions in healthcare facilities.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.40
自引率
6.70%
发文量
289
审稿时长
3-8 weeks
期刊介绍: Infection Control and Hospital Epidemiology provides original, peer-reviewed scientific articles for anyone involved with an infection control or epidemiology program in a hospital or healthcare facility. Written by infection control practitioners and epidemiologists and guided by an editorial board composed of the nation''s leaders in the field, ICHE provides a critical forum for this vital information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信